March 23, 2018 / 12:53 PM / 3 months ago

BRIEF-CHMP Recognizes That Amgen's Repatha Prevents Heart Attacks And Strokes

1 分钟阅读

March 23 (Reuters) - Amgen Inc:

* AMGEN RECEIVES POSITIVE CHMP OPINION RECOGNIZING THAT REPATHA (EVOLOCUMAB) PREVENTS HEART ATTACKS AND STROKES

* AMGEN INC - RECOMMENDED LABEL INCLUDES NEW INDICATION BASED ON REPATHA CARDIOVASCULAR OUTCOMES STUDY Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below